ES2192937B1 - Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv). - Google Patents

Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv).

Info

Publication number
ES2192937B1
ES2192937B1 ES200101232A ES200101232A ES2192937B1 ES 2192937 B1 ES2192937 B1 ES 2192937B1 ES 200101232 A ES200101232 A ES 200101232A ES 200101232 A ES200101232 A ES 200101232A ES 2192937 B1 ES2192937 B1 ES 2192937B1
Authority
ES
Spain
Prior art keywords
infectivity
hemorragical
viric
vhsv
rhabdovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200101232A
Other languages
English (en)
Other versions
ES2192937A1 (es
Inventor
Amparo Estepa Perez
Luis Perez Garcia-Estañ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Miguel Hernandez de Elche UMH
Original Assignee
Universidad Miguel Hernandez de Elche UMH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Miguel Hernandez de Elche UMH filed Critical Universidad Miguel Hernandez de Elche UMH
Priority to ES200101232A priority Critical patent/ES2192937B1/es
Publication of ES2192937A1 publication Critical patent/ES2192937A1/es
Application granted granted Critical
Publication of ES2192937B1 publication Critical patent/ES2192937B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Los péptidos activan la infectividad de VHSV y pueden utilizarse para aumentar la sensibilidad de tests de diagnóstico de dicho virus basados en la infectividad viral, en una muestra sospechosa de contener VHSV, así com en la elaboración de vacunas y vectores virales útiles en terapia génica.
ES200101232A 2001-05-29 2001-05-29 Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv). Expired - Fee Related ES2192937B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200101232A ES2192937B1 (es) 2001-05-29 2001-05-29 Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv).

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101232A ES2192937B1 (es) 2001-05-29 2001-05-29 Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv).

Publications (2)

Publication Number Publication Date
ES2192937A1 ES2192937A1 (es) 2003-10-16
ES2192937B1 true ES2192937B1 (es) 2005-01-01

Family

ID=29724679

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101232A Expired - Fee Related ES2192937B1 (es) 2001-05-29 2001-05-29 Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv).

Country Status (1)

Country Link
ES (1) ES2192937B1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244529B (it) * 1991-01-30 1994-07-15 Ist Superiore Sanita Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1

Also Published As

Publication number Publication date
ES2192937A1 (es) 2003-10-16

Similar Documents

Publication Publication Date Title
Henchal et al. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay.
AR118465A1 (es) Vectores de virus adenoasociados recombinantes
TW200512457A (en) Method of diagnosing SARS corona virus infection
ES2629380T3 (es) Viriones de AAV con inmunorreactividad reducida y usos de los mismos
AR038568A1 (es) Anticuerpos anti-a beta y su uso
CY1108299T1 (el) Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου
ES2083764T3 (es) Vacuna contra el sindrome respiratorio reproductivo porcino (srrp) y diagnostico.
EA200801756A1 (ru) Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса
MX341842B (es) Virus de la influenza capaces de infectar canidos y usos de los mismos.
AR071220A1 (es) Astrovirus aviario depositado bajo el nuero cncm i-3895
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
EP4526681A4 (en) Recombinant antibodies, kits containing them, and their uses in the diagnosis of African swine fever virus
DE60330966D1 (de) Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber
ES2187504T3 (es) Vectores no oncovirales, basados en el vmmp, con encapsidacion defectuosa.
Chow et al. Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike protein is sufficient to induce apoptosis in Vero E6 cells
ES2421543T3 (es) Método para la preparación de virus y proteínas del PRRS, y kits de pruebas de diagnóstico para su detección
AR067439A1 (es) Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4
ES2192937B1 (es) Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv).
AR124384A1 (es) Parapoxvirus modificado que tiene inmunogenicidad aumentada
DE602004030824D1 (de) An der oberfläche befindliche campylobacter jejuni-polypeptide
WO2010121013A3 (en) Molecularly imprinted polymers for detecting hiv-1
Marttila et al. Characterization of T cell epitopes in measles virus nucleoprotein
DK1200132T4 (da) Nucleinsyre-og aminosyresekvenser af infektiøs lakseanæmivirus og deres anvendelse som vacciner
FI923020A0 (fi) Inte a inte b-sekvenser.
Fenwick et al. A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20031016

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2192937B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20210903